| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |